The deep brain stimulation devices market is anticipated to grow at a CAGR of 10.33% from US$1,979.749 million in 2025 to ...

The company’s MySalvia system uses neuromodulation to alleviate the frequency and intensity of chronic migraines.

Persons with Parkinson's disease increasingly lose their mobility over time and are eventually unable to walk. Hope for these ...

Deep brain stimulation (DBS) is often used in refractory cases of Parkinson’s disease as well as in a number of other movement disorders. Electrodes are placed in deep nuclei of the brain ...

A research team led by Professor Jang Jin-woo of Neurosurgery at Korea University Anam Hospital successfully treated patients ...